Status:
COMPLETED
Patient Activation After DXA Result Notification
Lead Sponsor:
Fredric D Wolinsky
Collaborating Sponsors:
University of Alabama at Birmingham
Kaiser Permanente
Conditions:
Osteoporosis
Bone Diseases, Metabolic
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
There is growing evidence that patients undergoing bone mineral density testing (BMD) often do not take important steps to improve their bone health. The investigators will conduct a randomized-contro...
Detailed Description
Bone mineral density (BMD) peaks in early adulthood and declines progressively with aging. As BMD declines from normal, to low (formerly called osteopenia), to osteoporosis, risk of fractures progress...
Eligibility Criteria
Inclusion
- patients presenting for DXA
- age 50 years of age or older
Exclusion
- non-English speakers
- prisoners
- people who have mental disabilities
- individuals younger than age 50 years
- individuals who do not have access to a telephone
- deaf patients
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
7749 Patients enrolled
Trial Details
Trial ID
NCT01507662
Start Date
February 1 2012
End Date
November 1 2015
Last Update
November 10 2020
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294
2
Kaiser Permanente Georgia
Atlanta, Georgia, United States, 30305
3
University of Iowa
Iowa City, Iowa, United States, 52242
4
University of Toronto
Toronto, Ontario, Canada, M5S 1A1